ANTONIO GARCIA MERINO: Open Payments
NPI 1861635989 · MARTINSBURG, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$661 in 27 payments from 13 companies in 2025. Trend: 2023 $105 · 2024 $240 · 2025 $661
Food & beverage: $661
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 4 | $119 |
| Teva Pharmaceuticals USA, Inc. | 4 | $103 |
| Alkermes, Inc. | 4 | $88 |
| Janssen Pharmaceuticals, Inc | 3 | $69 |
| ABBVIE INC. | 3 | $62 |
| Indivior Inc. | 1 | $61 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $57 |
| Braeburn Inc. | 1 | $20 |
| Lilly USA, LLC | 1 | $19 |
| E.R. Squibb & Sons, L.L.C. | 1 | $18 |
Products named: INGREZZA, AUSTEDO XR, VRAYLAR, SUBLOCADE, CAPLYTA, INVEGA SUSTENNA, ARISTADA, SPRAVATO.
Industry payments across WV — which companies pay providers there.
